has been cited by the following article(s):
|
[1]
|
Theranostic Potential of Copper-64 ATSM Targeting MTHFD2: An In Silico Perspective on Hypoxia-Selective Imaging and Therapy
Cell Biochemistry and Biophysics,
2025
DOI:10.1007/s12013-025-01732-3
|
|
|
|
|
[2]
|
A Novel Cystatin Gene from Sea Cucumber (Apostichopus japonicus): Characterization and Comparative Expression with Cathepsin L During Early Stage of Hypoxic Exposure-Induced Autolysis
Foods,
2025
DOI:10.3390/foods14081404
|
|
|
|
|
[3]
|
Schweinfurthiamide as a Promising Anticancer Agent: Molecular Docking, Dynamics, and ADMET Insights Targeting MTHFD2
Journal of Pharmaceutical Innovation,
2025
DOI:10.1007/s12247-025-10092-7
|
|
|
|
|
[4]
|
Exploring the Anticancer Potential of Furanpydone A: A Computational Study on its Inhibition of MTHFD2 Across Diverse Cancer Cell Lines
Cell Biochemistry and Biophysics,
2024
DOI:10.1007/s12013-024-01474-8
|
|
|
|
|
[5]
|
Targeting allosteric binding site in methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) to identify natural product inhibitors via structure-based computational approach
Scientific Reports,
2023
DOI:10.1038/s41598-023-45175-3
|
|
|
|